Orion Portfolio Solutions, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Orion Portfolio Solutions, LLC
- $9.52 Billion
- Q4 2024
A detailed history of Orion Portfolio Solutions, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 16,721 shares of CRNX stock, worth $611,988. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,721
Previous 18,236
8.31%
Holding current value
$611,988
Previous $931,000
8.27%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRNX
# of Institutions
253Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$333 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$254 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$228 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$225 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$198 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.97B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...